Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bionomics Ltd ADR (BNOX)

Bionomics Ltd ADR (BNOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Bionomics Limited Receives Court Approval for Re-Domiciliation Scheme to Neuphoria Therapeutics Inc. Quiver Quantitative, Inc. - Tue Dec 17, 2024

Bionomics Limited's re-domiciliation scheme to the U.S. has been approved by the Supreme Court of New South Wales.Quiver AI SummaryBionomics Limited has received approval from the Supreme Court of New...

BNOX : 0.2531 (+4.20%)
Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation GlobeNewswire - Mon Dec 16, 2024

BNOX : 0.2531 (+4.20%)
Bionomics Limited Shareholders Approve Re-Domiciliation to the United States with Neuphoria Therapeutics Inc. as New Parent Company Quiver Quantitative, Inc. - Fri Dec 13, 2024

Bionomics shareholders approved the re-domiciliation to the US, pending final court and expert approvals.Quiver AI SummaryBionomics Limited has announced that its shareholders have approved the re-domiciliation...

BNOX : 0.2531 (+4.20%)
Results of Scheme Meeting GlobeNewswire - Thu Dec 12, 2024

BNOX : 0.2531 (+4.20%)
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence GlobeNewswire - Mon Dec 9, 2024

BNOX : 0.2531 (+4.20%)
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting GlobeNewswire - Tue Dec 3, 2024

BNOX : 0.2531 (+4.20%)
Bionomics Limited Urges Shareholders to Vote for U.S. Re-Domiciliation Proposal Quiver Quantitative, Inc. - Tue Dec 3, 2024

Bionomics urges shareholders to support its re-domiciliation from Australia to the U.S. ahead of upcoming votes.Quiver AI SummaryBionomics Limited, a biotechnology company focused on developing novel treatments...

BNOX : 0.2531 (+4.20%)
Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States GlobeNewswire - Mon Dec 2, 2024

BNOX : 0.2531 (+4.20%)
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement GlobeNewswire - Fri Nov 8, 2024

BNOX : 0.2531 (+4.20%)
Bionomics to Present at the 2024 CNS Summit GlobeNewswire - Thu Nov 7, 2024

BNOX : 0.2531 (+4.20%)

Barchart Exclusives

The Saturday Spread: Using Risk Topography to Plan Your Options Strategies (JD, NTAP, ZS) Barchart - Sat Dec 27, 9:15AM CST
While derivatives offer significant upside potential, trading these contracts requires precision. Here’s how to get a leg up, even against Wall Street pros. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot